Manatuck Hill Partners’s DNA X Inc SONM Stock Holding History

Manatuck Hill Partners’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-774	Closed	-$1.14M	–	170
2021 Q1	$1.14M	Hold	774	–	–	0.39%	58
2020 Q4	$1.01M	Sell	774 -59	-7%	-$64.4K	0.4%	59
2020 Q3	$1.16M	Buy	833 +111	+15%	+$178K	0.53%	51
2020 Q2	$1.04M	Buy	+722	New	+$1.15M	0.6%	40
2019 Q3	–	Sell	-47	Closed	-$1.07M	–	105
2019 Q2	$1.07M	Buy	+47	New	+$1.19M	0.5%	48

Other funds holding SONM

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DAS

Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Manatuck Hill Partners's SONM Position: Q2 2021 in Review

Manatuck Hill Partners sold out of DNA X Inc (SONM) in Q2 2021, closing a stake of 774 shares — an estimated $1.14M sold.

Manatuck Hill Partners first reported a position in SONM in Q2 2019 and held it in 5 quarters. The position peaked at $1.16M in Q3 2020. 17 funds tracked by Wall St. Rank hold SONM as of Q2 2021.

Manatuck Hill Partners reported no remaining DNA X Inc position as of Q2 2021 after selling out during the quarter.
Manatuck Hill Partners sold 774 DNA X Inc shares in Q2 2021, an estimated $1.14M.
Manatuck Hill Partners first reported a position in DNA X Inc in Q2 2019 and held it in 5 quarters.
Manatuck Hill Partners's DNA X Inc position peaked at $1.16M in Q3 2020.
17 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2021.

Based on Manatuck Hill Partners's 13F filing for Q2 2021, filed 16 Aug 2021.